Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
---|
04/01/2010 | US20100080830 Systemic delivery of antiviral agents |
04/01/2010 | US20100080824 A formulation comprising a cell culture extract of an isolated virus is identified to be morphologically and phylogenetically similar to the known member of coronaviruses; kits comprising containers containing the formulation used in medical diagnosis, as vaccines and antibodies |
04/01/2010 | US20100080818 Expression and Characterization of HIV-1 Envelope Protein Associated with Broadly Cross Reactive Neutralizing Antibody Response |
04/01/2010 | US20100080813 Neutralizing anti-influenza a virus antibodies and uses thereof |
04/01/2010 | US20100080807 Methods and Compositions for Treating Viral Hemorrhagic Fever |
04/01/2010 | US20100080792 Method for Identifying a MHC Class II-Dependent Tumor-Associated T Helper Cell Antigen |
04/01/2010 | US20100080771 Hepatitis C Virus Inhibitors |
04/01/2010 | US20100080760 Method, device, and system to control pH in pulmonary tissue of a subject |
04/01/2010 | CA2738477A1 Therapeutic regimen comprising peg- interferon, ribavirin and vx-950 for the treatment of hepatitis |
04/01/2010 | CA2738280A1 Peptide compound and method for producing the same |
04/01/2010 | CA2738252A1 Human anti-pd-1, pd-l1, and pd-l2 antibodies and uses therefor |
04/01/2010 | CA2738147A1 Solid pharmaceutical composition |
04/01/2010 | CA2738128A1 Herbal composition and method for the treatment of viral infection |
04/01/2010 | CA2738027A1 Monoclonal anti-claudin 1 antibodies for the inhibition of hepatitis c virus infection |
04/01/2010 | CA2737958A1 Hepatitis c inhibitor compounds |
04/01/2010 | CA2737948A1 Host cell kinases as targets for antiviral therapies against hcv infection |
04/01/2010 | CA2736880A1 1,2,3,6-tetrahydroazepino[4,5-b]indole-5-carboxylate nuclear receptor inhibitors |
04/01/2010 | CA2736472A1 Pyrine or pyrazine derivatives for treating hcv |
04/01/2010 | CA2723086A1 Antiviral drugs for treatment of arenavirus infection |
03/31/2010 | EP2169073A1 Vector for the preparation of immunotherapeutical compositions |
03/31/2010 | EP2169072A1 Multiple RNA polymerase III promoter expression constructs |
03/31/2010 | EP2169054A1 Vaccine for swine edema disease |
03/31/2010 | EP2168987A1 Multifunctional linker protein containing an antibody against hemagglutinin, a conserved influenza antigen and an immunostimulating carrier binding domain |
03/31/2010 | EP2168984A1 Human antibodies that bind human IL-12 and methods for producing |
03/31/2010 | EP2168972A2 Preparation and use of carbohydrate-based ring structures with antimicrobial and cytostatic activity |
03/31/2010 | EP2168951A1 Azolylmethylenehydrazine derivative and use thereof |
03/31/2010 | EP2168598A1 Method of Treatment Using Ligand-Immunogen Conjugates |
03/31/2010 | EP2168597A1 Vaccines comprising aluminium adjuvants and histidine |
03/31/2010 | EP2168596A2 Immunisation against chlamydia trachomatis |
03/31/2010 | EP2168595A1 Pharmaceutical compositions containing the protein nmb1796 |
03/31/2010 | EP2168593A1 Oral vaccine compositions |
03/31/2010 | EP2167662A2 Pharmaceutical compounds comprising abasic oligonucleotides |
03/31/2010 | EP2167537A2 Compiled methods for analysing and sorting samples |
03/31/2010 | EP2167536A1 Mhc multimers, methods for their generation, labeling and use |
03/31/2010 | EP2167527A2 Lantibiotic-based compounds having antimicrobial activity |
03/31/2010 | EP2167522A2 Triazole-based aminoglycoside-peptide conjugates and methods of use |
03/31/2010 | EP2167494A1 3-amino-6-(1-amino-ethyl)-tetrahydropyran derivatives |
03/31/2010 | EP2167490A1 Triazole derivatives having antifungal activity, method for the preparation thereof, and pharmaceutical composition comprising the same |
03/31/2010 | EP2167480A2 Cationic lipids compositions and methods for enhancing immune responses to vaccines |
03/31/2010 | EP2167476A2 Novel hiv reverse transcriptase inhibitors |
03/31/2010 | EP2167196A1 Heterocyclic compounds for the treatment of tuberculosis |
03/31/2010 | EP2167121A1 Vaccine comprising streptococcus pneumoniae capsular polysaccharide conjugates |
03/31/2010 | EP2167120A2 Vaccine comprising streptococcus pneumoniae capsular polysaccharide conjugates |
03/31/2010 | EP2167097A2 Metal complexes incorporated within biodegradable nanoparticles and their use |
03/31/2010 | EP2167089A1 Therapeutic compositions and the use thereof |
03/31/2010 | EP2167088A1 Therapeutic compositions and the use thereof |
03/31/2010 | EP2167074A2 Antibiotic compounds |
03/31/2010 | EP2167073A1 Terpenes with antifungal activity against malassezia yeasts |
03/31/2010 | EP2167027A1 The use of oestrogen applied to the penis to reduce hiv infection |
03/31/2010 | EP1301194B1 Essential oil combination and therapeutic uses thereof |
03/31/2010 | EP1251869B1 Immunogenic live rotavirus compositions with reduced risk of side effects |
03/31/2010 | EP1194168B1 Methods and products for manipulating uncoupling protein expression |
03/31/2010 | CN101687909A Composition for preventing or treating lung disease |
03/31/2010 | CN101687900A Double-stranded locked nucleic acid compositions |
03/31/2010 | CN101687887A Tricyclic nitrogen containing compounds as antibacterial agents |
03/31/2010 | CN101687884A macrolactone derivatives |
03/31/2010 | CN101687871A Spiro condensed barbituric acid derivatives for use as antibacterial |
03/31/2010 | CN101687870A Nitrogenous heterocyclic compounds, preparation thereof and use thereof as antibacterial medicaments |
03/31/2010 | CN101687808A indazolamide derivatives |
03/31/2010 | CN101687047A Targeted split biomolecular conjugates for the treatment of diseases, malignancies and disorders, and methods of their production |
03/31/2010 | CN101687044A Formulations for the oral administration of therapeutic agents and related methods |
03/31/2010 | CN101687028A 疫苗 Vaccine |
03/31/2010 | CN101687027A immunogenic compositions comprising mycobacterium tuberculosis polypeptides and fusions thereof |
03/31/2010 | CN101686995A Modulation of intestinal flora of HIV patients |
03/31/2010 | CN101686990A Antiviral agent |
03/31/2010 | CN101686985A Cytotoxic t cell activator comprising ep4 agonist |
03/31/2010 | CN101686972A Therapeutic compositions and the use thereof |
03/31/2010 | CN101686958A Topical fungicidal agents for treating nail disorders |
03/31/2010 | CN101684162A Preparation method of subprostrata sophora polysaccharide sulfate and subprostrata sophora polysaccharide sulfate prepared by using the method |
03/31/2010 | CN101684148A Novel surface protein of neisseria meningitidis |
03/31/2010 | CN101684147A moraxella catarrhalis proteins |
03/31/2010 | CN101684146A Novel hcv non-structural polypeptide |
03/31/2010 | CN101684116A Isoniazid lipid derivate and compositions thereof |
03/31/2010 | CN101684101A Piperazinone substituted tetracycline derivatives |
03/31/2010 | CN101684084A Tetracycline compounds containing carbamido |
03/31/2010 | CN101683525A Treatment of fungal infections with polyene or beta glucan synthase inhibitor antifungals combined with anti hsp90 antibodies |
03/31/2010 | CN101683524A Method for preparing bacterial ghost by combination of antibacterial peptide and ultrahigh pressure and application thereof |
03/31/2010 | CN101683519A Composition of thymic peptide alpha 1 and thymopeptide-5 and preparation method thereof |
03/31/2010 | CN101683510A Chinese medicine patch for treating cold and pain and method for producing the same |
03/31/2010 | CN101683490A Chinese medicinal granule preparation for preventing and treating influenza A(H1N1) virus occurring in humans and pigs |
03/31/2010 | CN101683469A Traditional Chinese medicine formula for treating dysentery |
03/31/2010 | CN101683452A Animal Chinese medicine oral liquid for preventing and treating infectious bursal disease of fowl and preparation method thereof |
03/31/2010 | CN101683437A Traditional Chinese medicine composition for soothing liver and strengthening spleen and nourishing qi and promoting blood circulation and preparation method thereof |
03/31/2010 | CN101683429A Animal Chinese medicine granular formulation for preventing and treating infectious bursal disease of fowl and preparation method thereof |
03/31/2010 | CN101683423A Application of Chinese medicine composition in preparation of medicament for treating chicken pox |
03/31/2010 | CN101683411A Application of crab apple extract in preparing hepatic or health-care food |
03/31/2010 | CN101683404A Traditional Chinese medicine composition for treating dampness and heat in liver and gallbladder and preparation method thereof |
03/31/2010 | CN101683403A Traditional Chinese medicine composition for treating hepatitis B and preparation method thereof |
03/31/2010 | CN101683396A Extraction method of tropaeolum total lavonoids |
03/31/2010 | CN101683395A Preparation method of anti-avian influenza virus, newcastle disease virus, chicken bursa virus specific transfer and antimicrobial peptide |
03/31/2010 | CN101683389A Injection for treating postpartum comprehensive disease of cattle and preparation method thereof |
03/31/2010 | CN101683369A Medicament for treating skin tinea disease |
03/31/2010 | CN101683366A Pharmaceutical composition for treating colibacillosis of fowl and preparation method thereof |
03/31/2010 | CN101683360A Extraction and purifying technology of propolis flavones and anticancer mechanism thereof |
03/31/2010 | CN101683357A Astragalus polyose solution for aquatic animals and preparation method thereof |
03/31/2010 | CN101683352A Helminthic for aquaculture of aquatic animal and preparation method thereof |
03/31/2010 | CN101683351A Application of phlorizin in preparing hepatic or health-care food |
03/31/2010 | CN101683349A Compound florfenicol powder for treating mycoplasma of pigeon and preparation method thereof |
03/31/2010 | CN101683334A (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione: methods of using and compositions thereof |
03/31/2010 | CN101683328A Sterilizing agent for aquaculture |